Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Assessment and clinical relevance of non-fasting and postprandial triglycerides : an expert panel statement. / Kolovou, Genovefa D; Mikhailidis, Dimitri P; Kovar, Jan; Lairon, Dennis; Nordestgaard, Børge G; Ooi, Teik Chye; Perez-Martinez, Pablo; Bilianou, Helen; Anagnostopoulou, Katherine; Panotopoulos, George.

I: Current Vascular Pharmacology, Bind 9, Nr. 3, 2011, s. 258-70.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Kolovou, GD, Mikhailidis, DP, Kovar, J, Lairon, D, Nordestgaard, BG, Ooi, TC, Perez-Martinez, P, Bilianou, H, Anagnostopoulou, K & Panotopoulos, G 2011, 'Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement', Current Vascular Pharmacology, bind 9, nr. 3, s. 258-70.

APA

Kolovou, G. D., Mikhailidis, D. P., Kovar, J., Lairon, D., Nordestgaard, B. G., Ooi, T. C., Perez-Martinez, P., Bilianou, H., Anagnostopoulou, K., & Panotopoulos, G. (2011). Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Current Vascular Pharmacology, 9(3), 258-70.

Vancouver

Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC o.a. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Current Vascular Pharmacology. 2011;9(3):258-70.

Author

Kolovou, Genovefa D ; Mikhailidis, Dimitri P ; Kovar, Jan ; Lairon, Dennis ; Nordestgaard, Børge G ; Ooi, Teik Chye ; Perez-Martinez, Pablo ; Bilianou, Helen ; Anagnostopoulou, Katherine ; Panotopoulos, George. / Assessment and clinical relevance of non-fasting and postprandial triglycerides : an expert panel statement. I: Current Vascular Pharmacology. 2011 ; Bind 9, Nr. 3. s. 258-70.

Bibtex

@article{ad180a022e234108a2efec7b35886af4,
title = "Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement",
abstract = "An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is",
author = "Kolovou, {Genovefa D} and Mikhailidis, {Dimitri P} and Jan Kovar and Dennis Lairon and Nordestgaard, {B{\o}rge G} and Ooi, {Teik Chye} and Pablo Perez-Martinez and Helen Bilianou and Katherine Anagnostopoulou and George Panotopoulos",
year = "2011",
language = "English",
volume = "9",
pages = "258--70",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers",
number = "3",

}

RIS

TY - JOUR

T1 - Assessment and clinical relevance of non-fasting and postprandial triglycerides

T2 - an expert panel statement

AU - Kolovou, Genovefa D

AU - Mikhailidis, Dimitri P

AU - Kovar, Jan

AU - Lairon, Dennis

AU - Nordestgaard, Børge G

AU - Ooi, Teik Chye

AU - Perez-Martinez, Pablo

AU - Bilianou, Helen

AU - Anagnostopoulou, Katherine

AU - Panotopoulos, George

PY - 2011

Y1 - 2011

N2 - An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is

AB - An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is

M3 - Journal article

VL - 9

SP - 258

EP - 270

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 3

ER -

ID: 40183968